Dr. Scheryll Alken

Dr. Scheryll Alken

Consultant in Adolescent and Young Adult Cancer, Children’s Health Ireland (CHI) at Crumlin

Dr Scheryll Alken, MB BCh BAO MRCPI, is Ireland’s first Consultant in Adolescent and Young Adult (AYA) Cancer based at Children’s Health Ireland, Crumlin and St James’s Hospital. She received her medical degree from The Royal College of Surgeons in Ireland in 2008, Membership of the Royal College of Physicians in Ireland in 2010 and her Certificate of Specialist Training in Medical Oncology from the Royal College of Physicians in Ireland in 2018. During her training, she undertook a two-year fellowship in Neuro-Oncology and Drug Development at the Royal Marsden Hospital/Institute of Cancer Research. In 2018, she was awarded an inaugural Aspire Clinical Fellowship in Adolescent and Young Adult Medical Oncology. She is a member of the National Cancer Control Programme’s Children, Adolescent & Young Adult Clinical Leads Group, developing Ireland’s National AYA Cancer Network and sits on the Executive Committee of the Trinity St James’s Cancer Institute. Her research interests include the disparities in care experienced by AYAs with cancer, transition in AYA cancer, and the role of exercise in this patient population, along with increasing clinical trial access for young people. She is a founding member of AYA Cancer Ireland, a special interest group for healthcare professionals in Ireland, and is proud to partner with young people with cancer to drive cancer research in Ireland

 

3D mammosphere culture of breast epithelial cell line MCF10A.

Courtesy of Dr. Emer Bourke, NUI Galway

Phospho-Akt expression and localisation

Mediated by VEGF in A549 lung cancer cells. Visualised by high content image analysis.

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

Metaphase chromosome spread of Jurkat T-lymphoma cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Apoptosis assessment of SKMES-1 lung cancer cells

Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

HeLa Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

IACR & EACR Joint Conference 2020

26 — 28 February 2020 at Galway Bay Hotel, Galway

Mitotic Chronic Myelogenous Leukaemia K562 Cells

Courtesy of Rebecca Gorry, PhD Student, Mc Gee Lab, UCD School of Biomolecular & Biomedical Science, Conway Institute, UCD

Cell to Cell Tweeting

Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)

Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.

Confocal Microscopy Analysis

Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).

Courtesy of Dr Martin Barr, Clinical Scientist & Adjunct Assistant Professor, St James’s Hospital & Trinity College Dublin

EACR Free Membership

The IACR is an affiliated national society and its members benefit from full membership of the EACR.

Save The Date

IACR 2023 Conference
Venue: Athlone Radisson Blu Hotel
Dates:
Wed 22/02/2023 – Fri 24/02/2023

Please check back later in the year for more information.

IACR in the Irish Independent

We supported the Cancer 2022 Campaign from @Mediaplanet

Latest News

FACEBOOK

Irish Association
for Cancer Research  

9A Coolkill, Sandyford
Dublin 18, Ireland
D18 C1W3

info@iacr.ie
+353 (0)295 8859

Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations, Charities Regulator, 3 George's Dock, IFSC, Dublin 1, D01 X5X0, Ireland.

Registered Charity Number (RCN): 20030117.

©Design by LetterEleven